-
1 Comment
Ercros, S.A is currently in a long term uptrend where the price is trading 30.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.5.
Ercros, S.A's total revenue sank by 2.5% to $141M since the same quarter in the previous year.
Its net income has dropped by 87.8% to $2M since the same quarter in the previous year.
Based on the above factors, Ercros, S.A gets an overall score of 2/5.
| Sector | Basic Materials |
|---|---|
| Industry | Chemicals |
| Exchange | F |
| CurrencyCode | EUR |
| ISIN | ES0125140A14 |
| PE Ratio | None |
|---|---|
| Beta | 0.64 |
| Market Cap | 226M |
| Target Price | None |
| Dividend Yield | None |
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, caustic potash, caustic soda, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and health and packaging items in the textile tanning industry. The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, anti-hypertensives, and anti-ulcer drugs. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CRS1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
